[1] Treatment of community-acquired methicillin-resistant Staphylococcus aureus in children

[2] Community-acquired methicillin-resistant Staphylococcus aureus in hospitalized adults and children without known risk factors

[3] Randomized, double-blind, placebo-controlled trial of cephalexin for treatment of uncomplicated skin abscesses in a population at risk for community-acquired methicillin-resistant Staphylococcus aureus infection

[4] Antibiotic treatment and the diagnosis of Streptococcus pneumoniae in lower respiratory tract infections in adults

[5] Targeted intranasal mupirocin to prevent colonization and infection by community-associated methicillin-resistant Staphylococcus aureus strains in soldiers: a cluster randomized controlled trial

[6] Increasing antimicrobial resistance and the management of uncomplicated community-acquired urinary tract infections